RAB38, also known as rrGTPbp and NY-MEL-1 [8], has been reported to be upregulated in glioblastoma, and high levels of its expression are associated with a poor prognosis and enhanced cell migration [9]. The gene discussed is RAB38; the disease is glioblastoma.